Postherpetic neuralgia
RW Johnson, ASC Rice - New England Journal of Medicine, 2014 - Mass Medical Soc
Key Clinical Points Postherpetic Neuralgia The frequencies of both herpes zoster and
postherpetic neuralgia increase with age. Postherpetic neuralgia results in suffering and …
postherpetic neuralgia increase with age. Postherpetic neuralgia results in suffering and …
Systematic review of incidence and complications of herpes zoster: towards a global perspective
K Kawai, BG Gebremeskel, CJ Acosta - BMJ open, 2014 - bmjopen.bmj.com
Objective The objective of this study was to characterise the incidence rates of herpes zoster
(HZ), also known as shingles, and risk of complications across the world. Design We …
(HZ), also known as shingles, and risk of complications across the world. Design We …
[HTML][HTML] Herpes zoster and postherpetic neuralgia: prevention and management
A Saguil, S Kane, M Mercado, R Lauters - American family physician, 2017 - aafp.org
Herpes zoster, or shingles, is caused by reactivation of varicella zoster virus, which causes
chickenpox. There are an estimated 1 million cases in the Unites States annually, with an …
chickenpox. There are an estimated 1 million cases in the Unites States annually, with an …
[HTML][HTML] A systematic review and meta-analysis of risk factors for postherpetic neuralgia
Patients with herpes zoster can develop persistent pain after rash healing, a complication
known as postherpetic neuralgia. By preventing zoster through vaccination, the risk of this …
known as postherpetic neuralgia. By preventing zoster through vaccination, the risk of this …
Quantification of risk factors for herpes zoster: population based case-control study
HJ Forbes, K Bhaskaran, SL Thomas, L Smeeth… - Bmj, 2014 - bmj.com
Objectives To quantify the effects of possible risk factors for herpes zoster at different ages.
Design Case-control study. Setting UK Clinical Practice Research Datalink primary care …
Design Case-control study. Setting UK Clinical Practice Research Datalink primary care …
Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective
RW Johnson, MJ Alvarez-Pasquin… - Therapeutic …, 2015 - journals.sagepub.com
Herpes zoster (HZ) is primarily a disease of nerve tissue but the acute and longer-term
manifestations require multidisciplinary knowledge and involvement in their management …
manifestations require multidisciplinary knowledge and involvement in their management …
Abnormal endogenous pain modulation is a shared characteristic of many chronic pain conditions
R Staud - Expert review of neurotherapeutics, 2012 - Taylor & Francis
The intensity of acute and chronic pain depends on interactions between peripheral impulse
input and CNS pain mechanisms, including facilitation and inhibition. Whereas tonic pain …
input and CNS pain mechanisms, including facilitation and inhibition. Whereas tonic pain …
Pathogenesis and current approaches to control of varicella-zoster virus infections
AA Gershon, MD Gershon - Clinical Microbiology Reviews, 2013 - Am Soc Microbiol
Varicella-zoster virus (VZV) was once thought to be a fairly innocuous pathogen. That view
is no longer tenable. The morbidity and mortality due to the primary and secondary diseases …
is no longer tenable. The morbidity and mortality due to the primary and secondary diseases …
Herpes zoster–typical and atypical presentations
RR Dayan, R Peleg - Postgraduate medicine, 2017 - Taylor & Francis
Varicella-zoster virus infection is an intriguing medical entity that involves many medical
specialties including infectious diseases, immunology, dermatology, and neurology. It can …
specialties including infectious diseases, immunology, dermatology, and neurology. It can …
[HTML][HTML] Epidemiology, treatment and prevention of herpes zoster: A comprehensive review
E Koshy, L Mengting, H Kumar, W Jianbo - Indian Journal of Dermatology …, 2018 - ijdvl.com
Herpes zoster is a major health burden that can affect individuals of any age. It is seen more
commonly among individuals aged≥ 50 years, those with immunocompromised status, and …
commonly among individuals aged≥ 50 years, those with immunocompromised status, and …